Abstract
The term "migrant variant" is not used in the headache classification of the International Headache Society (IHS), but it includes those forms of migraine that are not typical of migraine with or without aura. Headaches that do not quite fulfill all of the IHS criteria are termed "migrainous disorder." Migraine associated with auras arising from unusual sites includes basilar migraine, retinal migraine, and ophthalmoplegic migraine.
Two of the chromosomal sites for hemiplegic migraine have been identified. Migraine aura may occur without headache and an aura may be prolonged. Migrainous infarct has occurred when the aura lasts more than 1 week or imaging studies are positive and other etiologies have been ruled out. If the migraine attack is prolonged beyond 3 days the term "status migrainousus" is applied.
Similar content being viewed by others
References and Recommended Reading
Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(suppl 7):19–28.
Solomon S, Lipton RB: Criteria for the diagnosis of migraine in clinical practice. Headache 1991, 31:384–387.
Ducros A, Joutel A, Vahedi K, et al.: Genotype-phenotype correlations in familial hemiplegic migraine [abstract]. Neurology 1998, 50(suppl 4):A352.
Ducros A, Campbell JK: Familial hemiplegic migraine. In The Headaches, edn 2. Edited by Olesen J et al. Philadelphia: Lippincott Williams & Wilkins; 2000:501–505. The authors summarized the most recent genetic data of this condition. The two known loci of familial hemiplegic migraine are on chromosomes 1 and 19.
Joutel A, Bousser MG, Biousse V, et al.: A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993, 5:40–45.
Gardner K, Barmada MM, Ptacek LJ, et al.: A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 1997, 49:1231–1238.
Elliott MA, Peroutka SJ, Welch S, et al.: Familial hemiplegic migraine, nystagmus, and cerebellar atrophy. Ann Neurol 1996, 39:100–106.
Bradshaw PK, Parsons M: Hemiplegic migraine, a clinical study. Q J Med 1965, 133:65–85.
Tournier Lasserve E, Joutel A, Melki J, et al.: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993, 3:256–259.
Lai CW, Ziegler DK, Lansky LL, et al.: Hemiplegic migraine in childhood: diagnostic and therapeutic aspects. J Pediatr 1982, 101:696–699.
Rasmussen BK, Olesen J: Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992, 12:221–228.
Solomon S, Lipton RB, Harris PY: Arterial stenosis in migraine: spasm or arteriopathy? Headache 1990, 30:52–61.
Troist BT, Zagami AS: Ophthalmoplegic migraine and retinal migraine. In The Headaches, edn 2. Edited by Olesen J et al. Philadelphia: Lippincott Williams & Wilkins; 2000:511–516. In people with ophthalmoplegic migraine, paresis or paralysis of one or more nerves governing ocular motility are affected. During retinal migraine monocular visual defects are probably due to spasm of the ophthalmic artery or its branches.
Ostergaard JR, Moller HU, Christensen T: Recurrent ophthalmoplegia in childhood: diagnostic and etiologic considerations. Cephalalgia 1996, 16:27–69.
Wong V, Wong WC: Enhancement of oculomotor nerve-a diagnostic criterion for ophthalmoplegic migraine. Pediatr Neurol 1997, 17:70–73.
Maranhao-Filho PA, Martins-Ferreira H, Vincent MB, et al.: Sumatriptan blocks spreading depression in isolated chick retina. Cephalalgia 1997, 17:822–825.
Corbett JJ: Neuro-ophthalmic complications of migraine and cluster headaches. Neurol Clin 1983, 1:973–995.
McKendrick AM, Vingrys AJ, Badcock DR, et al.: Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci 2000, 41:1239–1247. Subclinical precortical visual field defects are found in people with migraine.
Brown GC, Margargal LE, Shields JA, et al.: Retinal arterial obstruction in children and young adults. Ophthalmology 1981, 88:18–25.
Kupersmith MJ, Hass WK, Chase NE: Isoproterenol treatment of visual symptoms in migraine. Stroke 1979, 10:299–305.
Fisher CM: Late-life migraine accompaniments: further experience. Stroke 1986, 17:1033–1042.
Merikangas KR, Fenton BT, Cheng SH, et al.: Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997, 54:362–368.
Chang CL, Donaghy M, Poulter N: Migraine and stroke in young women: case control study. BMJ 1999, 318:13–18.
Welch KMA, Bousser M-G: Migraine and stroke. In The Headaches, edn 2. Edited by Olesen J et al. Philadelphia: Lippincott Williams & Wilkins; 2000:529–542. The risk of stroke is greatest in women who have migraine with aura. That risk multiplies with the addition of such factors as smoking and the use of birth control pills.
Henrich JB, Sandercock PAG, Warlow CP, Jones LN: Stroke and migraine in the Oxfordshire Community Stroke Project. J Neurol 1986, 233:257–262.
Carolei A, Marini C, DeMatteis G: History of migraine and risk of cerebral ischemia in young adults. Lancet 1996, 347:1503–1506.
Robins M, Baum HM: The national survey of stroke. Incidence. Stroke 1981, 12(supp 1):I45–55.
Raskin NH: Treatment of status migrainosus: the American experience. Headache 1990, 30(suppl 2):550–553.
Mathew NT, Kailasam J: Repetitive intravenous administration of valproate sodium in intractable migraine: comparison with intravenous dihydroergotamine (DHE) [abstract]. Neurology 2000, 54(suppl 3):A22. Repetative intravenous valproate sodium is as effective as DHE in terminating an attack of intractable migraine.
Campbell JK, Zagami AS: Status migrainosus. In The Headaches, edn 2. Edited by Olesen J et al. Philadelphia: Lippincott Williams & Wilkins; 2000:525–528.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Solomon, S. Migraine variants. Current Science Inc 5, 165–169 (2001). https://doi.org/10.1007/s11916-001-0084-0
Issue Date:
DOI: https://doi.org/10.1007/s11916-001-0084-0